Supplemental Figure 3a from Phase Ib Study of Tirabrutinib in Combination with Idelalisib or Entospletinib in Previously Treated Chronic Lymphocytic Leukemia

Autor: Christopher D. Fegan, Juliane M. Jürgensmeier, Pankaj Bhargava, Ziqian Zhou, Xi Huang, Rita Humeniuk, Ping Cheng Yi, Siddhartha S. Mitra, Martin J.S. Dyer, Lionel Karlin, Ebenezer A. Kio, Simon A. Rule, Peter Hillmen, Harriet S. Walter, Charles Herbaux, Alexey V. Danilov
Rok vydání: 2023
DOI: 10.1158/1078-0432.22476726.v1
Popis: Supplemental Figure 3. Mean (SD) TIRA plasma concentration. Cycle 1 Day 8 data are shown in patients receiving TIRA monotherapy with A) TIRA/IDELA, and B) TIRA/ENTO*
Databáze: OpenAIRE